Connection Between Epigenome, Selective Mutability, Evolution, and Human Disease
Li, Harris et al., PLoS Genetics
Researchers at the Baylor College of Medicine and elsewhere propose a "connection between the epigenome, selective mutability, evolution, and human disease" based on the findings of their study on associations of structural mutability with germline DNA methylation and with non-allelic homologous recombination mediated by low-copy repeats. "Combined evidence from four human sperm methylome maps, human genome evolution, structural polymorphisms in the human population, and previous genomic and disease studies consistently points to a strong association of germline hypomethylation and genomic instability," the Baylor-led team writes.
IOM Report Urges FDA Shift from 510(k) Program
August 01, 2011
FDA is displeased with a new report from the IOM that recommends replacing the 510(k) program with a new one that blends pre-market and post-market review processes.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register quickly here for free access.
New to GenomeWeb? Register quickly here for free access.
Related Stories
- FDA Seeks Public Views on Proposed 510(k) Plans
August 1, 2011 / GenomeWeb Daily News - IoM to Study Effectiveness of FDA's 510(k) Review Process for Medical Devices
September 30, 2009 / Pharmacogenomics Reporter - FDA Clears Five Additional Pathogens for Idaho Technology's Respiratory Panel
May 15, 2012 / GenomeWeb Daily News - FDA Clears Gen-Probe's Panther MDx Platform
May 8, 2012 / GenomeWeb Daily News - Great Basin Receives 510(k) Clearance for C. difficile MDx Test
May 1, 2012 / GenomeWeb Daily News